Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the complete record of transactions filed by Rizzo Matthew, Director. Officer active across 1 company, notably Xtant Medical Holdings, Inc.. Cumulatively, 2 filings have been logged. Activity tracked since 15 August 2021. The latest transaction was filed on 15 August 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Matthew Rizzo is a Director at Xtant Medical Holdings, Inc. As a board member, he contributes to the governance of the company and strategic decision-making. His experience in the medical sector helps guide Xtant towards innovation initiatives.